Limits...
Efficacy of a mobile application for smoking cessation in young people: study protocol for a clustered, randomized trial.

Valdivieso-López E, Flores-Mateo G, Molina-Gómez JD, Rey-Reñones C, Barrera Uriarte ML, Duch J, Valverde A - BMC Public Health (2013)

Bottom Line: Tobacco consumption is the most preventable cause of morbidity-mortality in the world.Control group will receive the usual care.The outcome measure will be abstinence at 12 months confirmed by exhaled-air carbon monoxide concentration of at least 10 parts per million at each control test.

View Article: PubMed Central - HTML - PubMed

Affiliation: Centre d’Atenció Primària Bonavista, Direcció d’Atenció Primària Tarragona, Institut Català de la Salut, Tarragona, Spain.

ABSTRACT

Background: Tobacco consumption is the most preventable cause of morbidity-mortality in the world. One aspect of smoking cessation that merits in-depth study is the use of an application designed for smartphones (app), as a supportive element that could assist younger smokers in their efforts to quit. To assess the efficacy of an intervention that includes the assistance of a smoking cessation smartphone application targeted to young people aged 18 to 30 years who are motivated to stop smoking.

Methods/design: Cluster randomised clinical trial.

Setting: Primary Health Care centres (PHCCs) in Catalonia. Analyses based on intention to treat.

Participants: motivated smokers of 10 or more cigarettes per day, aged 18 to 30 years, consulting PHCCs for any reason and who provide written informed consent to participate in the trial. Intervention group will receive a 6-month smoking cessation programme that implements recommendations of a Clinical Practice Guideline, complemented with a smartphone app designed specifically for this programme. Control group will receive the usual care. The outcome measure will be abstinence at 12 months confirmed by exhaled-air carbon monoxide concentration of at least 10 parts per million at each control test.

Discussion: To our knowledge this is the first randomised controlled trial of a programme comparing the efficacy of usual care with a smoking cessation intervention involving a mobile app. If effective, the modality could offer a universal public health management approach to this common health concern.

Trial registration: NCT01734421.

Show MeSH
Flowchart: randomisation of centres, and sampling and monitoring of patients.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3750394&req=5

Figure 1: Flowchart: randomisation of centres, and sampling and monitoring of patients.

Mentions: During the recruitment period, or until the required quota of patients is reached, the family doctor and/or primary care nurse will invite patients aged 18 to 30 years who smoke 10 or more cigarettes per day to participate in the study. If the patient is eligible for inclusion and agrees to participate, informed consent will be requested (Figure 1). After signing informed consent, the participant’s demographic data will be collected and the study questionnaire will be administered (Fageström & Richmond). During this visit (visit 0) smokers with moderate motivation to stop smoking (Richmond score of 5–6) will be invited to schedule a second appointment to attempt to increase their motivation. For highly motivated participants (Richmond score of 7–10) a “quit day” will be established within the following 15 days (D-Day), and they will be invited to schedule an appointment for the day before their D-Day.


Efficacy of a mobile application for smoking cessation in young people: study protocol for a clustered, randomized trial.

Valdivieso-López E, Flores-Mateo G, Molina-Gómez JD, Rey-Reñones C, Barrera Uriarte ML, Duch J, Valverde A - BMC Public Health (2013)

Flowchart: randomisation of centres, and sampling and monitoring of patients.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3750394&req=5

Figure 1: Flowchart: randomisation of centres, and sampling and monitoring of patients.
Mentions: During the recruitment period, or until the required quota of patients is reached, the family doctor and/or primary care nurse will invite patients aged 18 to 30 years who smoke 10 or more cigarettes per day to participate in the study. If the patient is eligible for inclusion and agrees to participate, informed consent will be requested (Figure 1). After signing informed consent, the participant’s demographic data will be collected and the study questionnaire will be administered (Fageström & Richmond). During this visit (visit 0) smokers with moderate motivation to stop smoking (Richmond score of 5–6) will be invited to schedule a second appointment to attempt to increase their motivation. For highly motivated participants (Richmond score of 7–10) a “quit day” will be established within the following 15 days (D-Day), and they will be invited to schedule an appointment for the day before their D-Day.

Bottom Line: Tobacco consumption is the most preventable cause of morbidity-mortality in the world.Control group will receive the usual care.The outcome measure will be abstinence at 12 months confirmed by exhaled-air carbon monoxide concentration of at least 10 parts per million at each control test.

View Article: PubMed Central - HTML - PubMed

Affiliation: Centre d’Atenció Primària Bonavista, Direcció d’Atenció Primària Tarragona, Institut Català de la Salut, Tarragona, Spain.

ABSTRACT

Background: Tobacco consumption is the most preventable cause of morbidity-mortality in the world. One aspect of smoking cessation that merits in-depth study is the use of an application designed for smartphones (app), as a supportive element that could assist younger smokers in their efforts to quit. To assess the efficacy of an intervention that includes the assistance of a smoking cessation smartphone application targeted to young people aged 18 to 30 years who are motivated to stop smoking.

Methods/design: Cluster randomised clinical trial.

Setting: Primary Health Care centres (PHCCs) in Catalonia. Analyses based on intention to treat.

Participants: motivated smokers of 10 or more cigarettes per day, aged 18 to 30 years, consulting PHCCs for any reason and who provide written informed consent to participate in the trial. Intervention group will receive a 6-month smoking cessation programme that implements recommendations of a Clinical Practice Guideline, complemented with a smartphone app designed specifically for this programme. Control group will receive the usual care. The outcome measure will be abstinence at 12 months confirmed by exhaled-air carbon monoxide concentration of at least 10 parts per million at each control test.

Discussion: To our knowledge this is the first randomised controlled trial of a programme comparing the efficacy of usual care with a smoking cessation intervention involving a mobile app. If effective, the modality could offer a universal public health management approach to this common health concern.

Trial registration: NCT01734421.

Show MeSH